Dolly Parton COVID-19 Research Fund Archives
Monoclonal antibody “cocktail” blocks COVID-19 variants: study
Mar. 4, 2021—A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine.
A shot in the arm
Mar. 3, 2021—Country music icon Dolly Parton received her COVID-19 vaccination at Vanderbilt Health Tuesday from Naji Abumrad, MD, and urged everyone not to hesitate to get their vaccine when they become eligible to receive it.
Possible COVID-19 “decoy”
Oct. 15, 2020—It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.
Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19
Jul. 15, 2020—Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19.
